Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) has announced that its CEO, Sharon Mates, Ph.D., will present at the SVB Securities Global Biopharma Conference on February 15, 2023, at 10:40 a.m. ET. The conference aims to showcase innovations in biopharmaceuticals, with a focus on therapies for central nervous system disorders.

Participants can access the live and archived webcast through the Investor Relations section of the company's website. Intra-Cellular Therapies specializes in developing treatments for complex psychiatric and neurologic diseases, leveraging Nobel prize-winning research.

NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 10:40 a.m. ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

FAQ

When is the SVB Securities Global Biopharma Conference presentation by Intra-Cellular Therapies scheduled?

The presentation by Intra-Cellular Therapies is scheduled for February 15, 2023, at 10:40 a.m. ET.

Who is presenting for Intra-Cellular Therapies at the conference?

Sharon Mates, Ph.D., the Chief Executive Officer and Chairman, will be presenting for Intra-Cellular Therapies.

How can I access the Intra-Cellular Therapies conference presentation?

You can access the live and archived webcast under 'Events & Presentations' in the Investor Relations section of the Intra-Cellular Therapies website.

What does Intra-Cellular Therapies focus on developing?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

What is the stock symbol for Intra-Cellular Therapies?

The stock symbol for Intra-Cellular Therapies is ITCI.